Werewolf Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2026 | $32.1M | $12.2M | $46.5M |
| Jun 2026 | — | $16.3M | $22.0M |
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2026 | $32.1M | $12.2M | $46.5M |
| Jun 2026 | — | $16.3M | $22.0M |